Background: At present, the only definitive treatment for adult phimosis is circumcision, which is a surgical removal of the prepuce. Novoglan is a novel device that could offer patients with phimosis an alternative to surgery. It is based on application of custom-moulded balloons for gradual skin remodelling and prepuce dilatation. This open-label clinical trial aimed to investigate the safety, efficacy and tolerability of the Novoglan treatment.

Methods: A prospective trial was conducted on 20 patients with adult phimosis recruited at Macquarie University Hospital and Princess Alexandra Hospital. After eligibility screening and enrolment, patients were provided with the Novoglan product and training. The treatment involved twice daily 10-minute applications for a duration of 4-8 weeks with patient's degree of phimosis assessed before and at 6-8 weeks after the initiation of the treatment. Participants were also asked to complete questionnaires aimed to assess the safety and tolerability of the Novoglan treatment.

Results: The treatment was successful with improved foreskin retraction in 90% of patients and all patients achieving full foreskin retraction after the treatment. Ninety-five percent of patients reported reduced level of anxiety, and over 60% of patients reported reduced pain/discomfort during sexual activity or in general. Similarly, 95% of patients were moderately-to-very satisfied with the treatment and would recommend Novoglan to others. No adverse events were observed and only 15% of participants reported minor side effects.

Conclusions: The Novoglan-01 trial demonstrated high safety, efficacy and tolerability of the Novoglan treatment for adult phimosis and its high potential as a conservative alternative to circumcision or steroid cream treatment.

Trial Registration: The Novoglan-01 study has been registered with the Australia and New Zealand Clinical Trial Registry under the reference ACTRN 1262 10009 24853, dated 15 July 2021.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406538PMC
http://dx.doi.org/10.21037/tau-23-91DOI Listing

Publication Analysis

Top Keywords

adult phimosis
16
treatment adult
12
clinical trial
12
safety efficacy
12
efficacy tolerability
12
tolerability novoglan
12
treatment
8
open-label clinical
8
patients
8
foreskin retraction
8

Similar Publications

Objective: To compare the safety profile and clinical outcomes of Altieri-modified Nesbit corporoplasty using two different anesthesia methods including spinal anesthesia and local anesthesia.

Materials And Methods: A total of 40 patients with congenital penile curvature (CPC) and Peyronie's disease (PD) underwent Altieri-modified Nesbit corporoplasty. Group 1 (n = 20) received spinal anesthesia, and Group 2 (n = 20) received local anesthesia.

View Article and Find Full Text PDF

Background: This prospective nonrandomized controlled study aimed to compare the surgical outcomes, postoperative complications, and patient experiences between a modified circumcision technique using a disposable circumcision suture device and the standard circumcision method using a disposable circumcision suture device in Chinese patients with excess foreskin or phimosis at our department of urology and andrology.

Materials And Methods: A total of 456 patients underwent circumcision at our center from May 2021 to September 2022, with 228 patients in the modified disposable circumcision suture device group (mean age: 29.8 years; range: 16.

View Article and Find Full Text PDF

Circumcision is a commonly performed surgical procedure both in childhood and in adults. Acute ischemia of the glans penis after circumcision is a rare but hazardous complication. If left untreated, it can lead to severe consequences such as blackish discolouration due to ischemia, necrosis, or rare organ loss.

View Article and Find Full Text PDF
Article Synopsis
  • Circumcision is commonly performed for various reasons, and this study aimed to assess if routine histopathological examinations of foreskin specimens are necessary after adult circumcision.
  • A retrospective analysis of 334 male patients showed that only 2.7% had preoperative clinical suspicions, and among them, only 0.9% were found to have malignancy.
  • The majority of patients (97.3%) with no suspicious features preoperatively showed no signs of malignancy, suggesting routine histopathological examination may not be required for every case.
View Article and Find Full Text PDF

Background: Penile cancer (PeCa) is a rare disease. HPV infection, smoking, phimosis, and lichen sclerosus represent well-known associated risk factors.

Objectives: Primary aim of our study is to evaluate the incidence and risk factors of PeCa and to outline the adopted diagnostic and therapeutic approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!